Regeneron backs $75M series A for antibody upstart Infinimmune
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
25 trends tracked about this subject — the full history, oldest to newest below.
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
A scientist has employed gene-editing techniques to breed a dog designed specifically to avoid triggering his own personal pet allergies.
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
AbCellera shares surged after Phase 2 trial results for ABCL635 showed an 83% reduction in menopause-related hot flashes.
An AI system has designed 16 entirely new viruses after analyzing 9 trillion nucleotides to learn the patterns of DNA.
Large genome models have created sixteen new viruses from scratch, triggering warnings about potential misuse alongside drug-resistance research.
8 news sources are covering this Technology story right now — PULSE is tracking how fast it spreads.
Kindred Companion Sciences has used CRISPR gene-editing to create hypoallergenic beagles by removing a major allergy-causing protein.
Recent coverage highlights a scientific development involving a special enzyme designed to remove AGEs and de-age human tissue.
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
10 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Researchers are leveraging AlphaFold3's contact modelling to redesign gene-editing proteins for increased precision and safety in DNA base editing.
MIT engineers have developed a precise method to grow and redirect artificial blood vessels and microvascular networks using magnetic fields.
De-extinction startup Colossal Biosciences is reportedly pursuing a new funding round with a target valuation between $20 billion and $30 billion.
Scientists have discovered a biotechnology shortcut allowing plants to produce real bovine casein, creating a path toward cow-free dairy proteins.
An experimental Alzheimer's drug shows early promise while raising mixed questions and triggering a stock drop.
Anthropic is entering the biotech sector with Claude Science, a new research workbench designed for drug discovery and studying overlooked diseases.
A prime‑editing tool for filamentous fungi is producing novel anti‑cancer compounds, drawing biotech attention.
A new single-injection therapy has shown the ability to reverse chronic osteoarthritis in animal subjects over a four-week period.
5 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.
Anthropic has entered the drug discovery sector with the launch of a dedicated AI research workbench and the development of internal pre-clinical trials.
Researchers are developing genetically modified hookworms capable of producing and delivering therapeutic agents directly within a living host.
A human patient has received the first experimental therapy designed to reverse cellular aging in a bid to treat age-related vision loss.